Our event has been generously sponsored by the following exhibitors:
IKTOS (Exhibitor & Exclusively Sponsoring our Poster Prizes for the Poster Session on Monday 9th March)
Iktos is a French start-up company which develops an artificial intelligence technology for ligand- and structure-based de novo drug design. Our innovative algorithm is based on state-of-the-art deep learning models, called generative models, and enables to design new, druggable and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance. Iktos is offering ready-to-use AI solutions for medicinal chemistry projects (retrosynthesis and drug design) with utmost flexibility: SaaS with our softwares Spaya and Makya, on premise or via custom implementation.
CAS SciFinder (Exhibitor, Sponsoring Professor Peter Johnson’s Talk on Monday 9th March & Exclusively Sponsoring our Drinks Reception on Tuesday 10th March)
CAS, a division of the American Chemical Society specializing in scientific information solutions, partners with R&D organizations globally to provide actionable insights that help them plan, innovate, protect their innovations, and predict how new markets and opportunities will evolve. Scientific researchers, patent professionals and business leaders around the world across commercial, academic and government sectors rely on our solutions and services to advise discovery and strategy. Leverage our unparalleled content, specialized technology, and unmatched human expertise to customize solutions that will give your organization an information advantage. With more than 110 years’ experience, no one knows more about scientific information than CAS. Learn more at www.cas.org.
DeepMatter (Exhibitor)
DeepMatter’s long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors. The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster. In 2019, DeepMatter Group acquired InfoChem based in Munich, Germany. InfoChem has more than 30 years; experience in the development and integration of sophisticated software tools for the storage and handling of structure and reaction information. The company main activities involve the production of synthesis planning and reaction prediction solutions and the automatic extraction of scientific information from text and images.
Elsevier Reaxys (Exhibitor)
Description of product: Reaxys is a chemistry research and education database with chemical substance, properties, reaction and medicinal chemistry for both bench chemistry & machine learning insights supporting drug discovery and chemical R&D in industries such as pharmaceutical and chemicals
Web link: https://www.elsevier.com/solutions/reaxys
What will be demonstrated onsite at the event: Reaxys Predictive Retrosynthesis: developed in partnership with Prof Mark Waller based on the ground-breaking work in Nature showing artificial intelligence predicting successful synthetic routes for novel compounds 95% of the time
Merck (Exhibitor)
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2018, Merck KGaA, Darmstadt, Germany generated sales of €14.8 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in Healthcare, MilliporeSigma in Life Science, and EMD in Performance Materials.
Mettler Toledo (Exhibitor)
METTLER TOLEDO AutoChem is the world leader in providing technology for chemical synthesis and process development. Synthesis workstations enable screening, optimisation, automated sampling, and control of reaction parameters. ReactIR™, Particle Track® and Particle Vision® enable understanding of reaction progression, mechanisms, kinetics, and particle characterisation in situ and in real-time for batch and flow chemistry in lab and plant environments.
Molecule.one (Exhibitor)
Molecule.one provides software that designs ways to make organic molecules. Based on cutting-edge AI, their patent-pending technology leverages chemical datasets in order to propose novel synthesis pathways within a minute for typical drug-like molecules. Combined with a robust data curation pipeline and an interface built in accordance with chemists’ needs, Molecule.one aims to become the first market standard in computer-assisted organic synthesis planning.
Mcule (Exhibitor)
Mcule is a compound sourcing company headquartered in the EU and the US. We offer more than 45 million purchasable compounds from 100 chemical suppliers. Our team of chemical experts and scientists helps our professional partners with competent consulting services, assisting them through the whole process of compound sourcing, including filtering, price quotation and the actual purchase of the compounds. All this is supported by the online drug discovery platform developed by Mcule’s cheminformatics team. We also offer custom synthesis solutions by being in contact with more than 300 custom synthesis partners. Custom database integrations through API are also available, provided by our team of cheminformatics developers. We are currently working on an exciting new digital product called the Ultimate Database, which will open a new dimension in compound sourcing: a new, artificial chemical space of 500 million novel, diverse and synthetically feasible compounds.
NextMove Software (Exhibitor)
NextMove Software develops and markets scientific informatics software solutions for pharmaceutical and life sciences companies. Its unique products complement other vendors’ offerings, covering areas such as: ELN and reaction informatics; patent (chemical) text mining; peptide, oligosaccharide and biologics informatics; 2D chemical similarity; matched molecular series and ELN chemical hazard alerting.